Human Papilloma Virus (Batch)

Discover the latest on Medi Linx Laboratory

KNOW OUR DIRECTORY OF SERVICES

Explore our comprehensive test menu covering a wide range of medical specialties to support accurate diagnoses and patient management. From routine chemistry to advanced genomics—we’ve got you covered.

Human Papilloma Virus (Batch)

Test Information:
Qualitative in vitro test for the detection of Human Papillomavirus in patient specimens. The test utilizes amplification of target DNA by the PCR and nucleic acid hybridization for the detection of 14 HR HPV types in a single analysis. The test specifically identifies HPV16 and HPV18 while concurrently detecting the other high-risk types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) at clinically relevant infection levels. Specimens are limited to cervical cells collected in Roche Cell Collection Medium (Roche Molecular Systems, Inc.), PreservCyt Solution (Hologic Corp.) and SurePath Preservative Fluid (BD Diagnostics-TriPath).

Specimen Container:

  • SurePathTM Preservative Fluid
  • PreservCyt Solution
  • Roche Cell
  • Collection Medium

Specimen Type:
Cervical Specimen

Required Volume:
10 mL

Patient Preparation:
No Patient Preparation

Notes:
Do Not Freeze!

Storage & Stability
(Before Processing)

  • SurePath TM Preservative Fluid:
    Storage: Refrigerator temperature (2 – 8°C)
    Stability: up to 6 months
  • Storage: Room temperature (15 – 30°C)
    Stability: up to 6 weeks
  • PreservCyt® Solution Roche Cell Collection Medium:
    Storage: (2 – 30°C)
    Stability: up to 6 months

Transport Temperature:
Ref (2°C to 8°C)

Test Category:
Batch

Test Schedule:
Effective may 04, 2026
Running day: Monday – Friday (cut-off: 1200H)

Results Availability:
Effective May 04, 2026
Within 24Hrs:
Specimen received before 1200H (Monday to Friday)
Next day:
Specimen received 1201H onwards (Monday to Thursday)
Monday:
Specimen received 1201H onwards (Friday)

At MEDI LINX LABORATORY INC., we are committed to safeguarding the privacy and security of your personal and health-related information. This data privacy statement outlines how we collect, use, disclose, and protect your data to ensure compliance with applicable laws and regulations, including but not limited to Republic Act No. 10173, its Implementing Rules and Regulations, and the issuance/s set forth by the National Privacy Commission (NPC).

Click here to read the Data Privacy Statement in full.